The Analytical Scientist / Issues / 2026 / April / Honoring Chromatography Educator Peter W. Carr (1944–2025)
Voices in the Community Career Pathways Liquid Chromatography

Honoring Chromatography Educator Peter W. Carr (1944–2025)

We remember 2D-LC pioneer, devoted mentor, and “classic New Yorker,” Peter Carr 

By James Strachan 04/02/2026 3 min read

Share

Clinical Scorecard: Honoring Chromatography Educator Peter W. Carr (1944–2025)

At a Glance

CategoryDetail
ConditionLegacy in Analytical Chemistry and Chromatography Education
Key MechanismsInnovations in liquid chromatography, particularly with zirconia as a stationary phase.
Target PopulationGraduate students and postdoctoral researchers in analytical chemistry.
Care SettingAcademic institutions, particularly the University of Minnesota.

Key Highlights

  • Pioneered advancements in liquid chromatography and zirconia-based stationary phases.
  • Mentored over 100 graduate students and postdoctoral researchers.
  • Received multiple prestigious awards in analytical chemistry and education.
  • Founded the Minnesota Chromatography Forum to foster collaboration.
  • Recognized for his impactful teaching and direct mentorship style.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          Not applicable; focus on educational impact rather than clinical treatment.

          Emphasized the importance of practical applications in chromatography.

          Clinical Best Practices

          • Encourage collaboration among researchers and industry professionals.
          • Focus on practical utility in educational settings.
          • Provide comprehensive mentoring and professional preparation for students.

          Related Resources & Content

          About the Author(s)

          James Strachan

          Over the course of my Biomedical Sciences degree it dawned on me that my goal of becoming a scientist didn’t quite mesh with my lack of affinity for lab work. Thinking on my decision to pursue biology rather than English at age 15 – despite an aptitude for the latter – I realized that science writing was a way to combine what I loved with what I was good at. From there I set out to gather as much freelancing experience as I could, spending 2 years developing scientific content for International Innovation, before completing an MSc in Science Communication. After gaining invaluable experience in supporting the communications efforts of CERN and IN-PART, I joined Texere – where I am focused on producing consistently engaging, cutting-edge and innovative content for our specialist audiences around the world.

          More Articles by James Strachan

          Recommended

          Related Content

          The Climate Conversation: Part Two – Michael Gonsior
          Voices in the Community
          The Climate Conversation: Part Two – Michael Gonsior

          December 5, 2024

          7 min read

          In the second part of our interview, Michael Gonsior explores the pressing challenges in carbon cycle research, transformative tools and technologies, as well as analytical glimmers of hope

          Charting the Contaminant Iceberg: Part One
          Voices in the Community
          Charting the Contaminant Iceberg: Part One

          December 17, 2024

          5 min read

          Torsten C. Schmidt casts his eye on the contaminants of concern for the future and considers how much of the full picture current technology allows us to see – in the first of our two-part interview

          The Planet Protector
          Voices in the Community
          The Planet Protector

          December 20, 2024

          10 min read

          Sitting Down With… Damià Barceló Cullerès, Honorary Adjunct Professor, Chemistry and Physics Department, University of Almeria, Spain

          Stefan Foser on the Future of Pharma
          Voices in the Community
          Stefan Foser on the Future of Pharma

          November 13, 2024

          6 min read

          Earlier this year, Stefan Foser joined Bruker as VP of Global Pharma – following a successful career as a molecular biologist and pharma business leader. Here, he reflects on the importance of analytical technology in the post-genomic era.